ETODROXIZINE DIHYDROCHLORIDE

Possibly Marketed Outside US

Details

Stereochemistry	RACEMIC
Molecular Formula	C23H31ClN2O3.2ClH
Molecular Weight	491.879
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of ETODROXIZINE DIHYDROCHLORIDE

Structure Search

SMILES

Cl.Cl.OCCOCCOCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3

InChI

InChIKey=UDHAKRNMZHKNNW-UHFFFAOYSA-N

InChI=1S/C23H31ClN2O3.2ClH/c24-22-8-6-21(7-9-22)23(20-4-2-1-3-5-20)26-12-10-25(11-13-26)14-16-28-18-19-29-17-15-27;;/h1-9,23,27H,10-19H2;2*1H

HIDE SMILES / InChI

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C23H31ClN2O3
Molecular Weight	418.957
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: https://findwords.info/term/etodroxizine | https://www.ncbi.nlm.nih.gov/pubmed/5325387 | https://www.ncbi.nlm.nih.gov/pubmed/9296 | (2013) Pharmeceutical manufacturing encyclopedia, page 1525, retrieved from: https://books.google.ru/books?id=_J2ti4EkYpkC

Etodroxizine is a first-generation antihistamine of the diphenylmethane and piperazine classes. It is a sleep-inducing agent. Etodroxizine in combination with methaqualone had a somewhat stronger surpressive effect upon REM-sleep than methaqualone alone.

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:03:31 GMT 2025` Edited by `admin` on `Mon Mar 31 21:03:31 GMT 2025`
Record UNII	XS3P9E5BO8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ETODROXIZINE DIHYDROCHLORIDE

Common Name

English

ETHANOL, 2-(2-(2-(4-((4-CHLOROPHENYL)PHENYLMETHYL)-1-PIPERAZINYL)ETHOXY)ETHOXY)-, DIHYDROCHLORIDE

Preferred Name

English

Code System Code Type Description

PUBCHEM

154926041

Created by admin on Mon Mar 31 21:03:31 GMT 2025 , Edited by admin on Mon Mar 31 21:03:31 GMT 2025

PRIMARY

FDA UNII

XS3P9E5BO8